GNMSF - Genmab A/S (GMAB) CEO Jan van de Winkel on Q4 2020 Results - Earnings Call Transcript
Genmab A/S (GMAB) Q4 2020 Earnings Conference Call February 23, 2021, 12:00 ET Company Participants Jan van de Winkel - Co-Founder, President & CEO Anthony Pagano - EVP & CFO Anthony Mancini - EVP & COO Judith Klimovsky - EVP & Chief Development Officer Tahamtan Ahmadi - SVP Conference Call Participants Peter Verdult - Citigroup Emily Field - Barclays Bank Trung Huynh - Crédit Suisse Michael Novod - Nordea Markets Michael Schmidt - Guggenheim Securities Matthew Harrison - Morgan Stanley Carsten Madsen - SEB Jonathan Chang - SVB Leerink Wimal Kapadia - Sanford C. Bernstein & Co. Presentation Operator Hello, and welcome to the Genmab Q4 2020 Conference Call. [Operator Instructions]. During this telephone conference, you may be presented with forward-looking statements that include words such as believes, anticipates, plans or expects. Actual results may differ materially. For example, as a result of delayed or unsuccessful development projects. Genmab is
For further details see:
Genmab A/S (GMAB) CEO Jan van de Winkel on Q4 2020 Results - Earnings Call Transcript